Pharmacia Xalatan first-line use
Pharmacia Xalatan (latanoprost) receives FDA approval Dec. 20 as initial treatment for elevated eye pressure associated with open-angle glaucoma or ocular hypertension. The prostaglandin was previously approved for second line use...
You may also be interested in...
Emerging Company Profile: Aelix Therapeutics has constructed a potential therapeutic HIV vaccine to refocus the immune system onto vulnerable parts of the virus, and may allow patients to control viral replication without antiretroviral therapy.
Coherus BioSciences has sold a little under 2.5 million shares to partner Junshi Biosciences, giving the firm additional capital following a large debt financing last year.
A provisional list of CBD products that can continue to legally be sold in the UK has been issued by the Food Standards Agency. However the list currently only includes products from three suppliers and will not be complete until June 2021, meaning the vast majority of companies face a nervy wait.